Home LiteratureArticle Details
PMID: 14971660 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas.

Molecular and cellular biochemistry ·Vol. 255 ·No. 1-2 ·2004-01-00 ·Pages 195-202

Kowara R, Salnikow K, Diwan BA, Bare RM, Waalkes MP, Kasprzak KS

Abstract

Nickel compounds are carcinogenic and induce malignant transformation of cultured cells. Since nickel has low mutagenic potential, it may act predominantly through epigenetic mechanisms, including down-regulation of tumor suppressor genes. FHIT is a tumor suppressor gene whose expression is frequently reduced or lost in tumors and pre-malignant lesions. Previously, we have shown that the phosphohydrolase activity of Fhit protein, associated with its tumor suppressor action, is inhibited by nickel. In cells, such effect would assist in carcinogenesis. The latter could be further enhanced if nickel also lowered cellular levels of Fhit protein itself, e.g. by down-regulation of FHIT gene. To test this possibility, we determined Fhit protein and Fhit-mRNA levels in a nickel-transformed mouse cell line and in nickel-induced murine sarcomas. In B200 cells, derived by nickel treatment of BALB/c-3T3 cells and exhibiting a malignant phenotype, Fhit protein levels were 50% of those in the parental cells, while Fhit-mRNA expression remained unchanged. A decrease of up to > 90% in Fhit protein levels was also observed in 22 local sarcomas (mostly fibrosarcomas) induced by i.m. injection of nickel subsulfide in C57BL/6 and MT+ (C57BL/6 overexpressing metallothionein) mice, as compared with normal muscles. Moreover, Fhit was absent in 3 out of 10 sarcomas from MT+ mice and in 1 of 12 sarcomas from C57BL/6 mice. The lack of Fhit protein coincided with the absence of the Fhit-mRNA transcript in these tumors. However, in the other tumors, the decreased Fhit levels were not always accompanied by reduced expression of Fhit-mRNA. Thus, the observed lowering of Fhit protein levels is mostly associated with changes in mRNA expression and protein translation or turnover rates, and rarely with a full silencing of the gene itself. Overall, the decline of Fhit in cells or tissues malignantly transformed by nickel may indicate possible involvement of this effect in the mechanisms of nickel carcinogenesis.

MeSH Terms
Acid Anhydride Hydrolases/biosynthesis,genetics Animals Cell Line, Transformed Cell Transformation, Neoplastic/chemically induced,metabolism Mice Mice, Transgenic Muscle Neoplasms/chemically induced Neoplasm Proteins/biosynthesis,genetics,metabolism Nickel/toxicity Sarcoma, Experimental/chemically induced
Chemicals
Neoplasm Proteins fragile histidine triad protein Nickel Acid Anhydride Hydrolases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kowara Renata
Laboratory of Comparative Carcinogenesis, National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA.
Salnikow Konstantin
Diwan Bhalchandra A
Bare Robert M
Waalkes Michael P
Kasprzak Kazimierz S
References (37)
37 references, click to expand
  1. Characterization of metallothionein-I-transgenic mice.
    Toxicol Appl Pharmacol. 1995 Aug;133(2):305-12 PMID: 7645027
  2. Possible role of oxidative damage in metal-induced carcinogenesis.
    Cancer Invest. 1995;13(4):411-30 PMID: 7627727
  3. In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.
    Chem Res Toxicol. 2002 Mar;15(3):319-25 PMID: 11896678
  4. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Clin Cancer Res. 2001 Dec;7(12):3869-73 PMID: 11751477
  5. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents.
    Nucleic Acids Res. 1984 Feb 24;12(4):2137-45 PMID: 6701097
  6. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
    Biochemistry. 1996 Sep 10;35(36):11529-35 PMID: 8794732
  7. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
    Mol Med. 2001 Jul;7(7):442-53 PMID: 11683369
  8. Characterization of mouse cell lines resistant to nickel(II) ions.
    Cancer Res. 1988 Dec 1;48(23):6850-4 PMID: 3180093
  9. Role of FHIT in human cancer.
    J Clin Oncol. 1999 May;17(5):1618-24 PMID: 10334551
  10. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Cancer Res. 2000 Jun 1;60(11):2780-5 PMID: 10850413
  11. Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol.
    J Inorg Biochem. 1982 Aug;17(1):29-39 PMID: 7119773
  12. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice.
    Mol Cell Biol. 1993 Sep;13(9):5266-75 PMID: 8355681
  13. The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.
    Cancer Res. 1998 Aug 1;58(15):3401-8 PMID: 9699672
  14. The importance of proteins in defense against oxidation.
    Antioxid Redox Signal. 2001 Apr;3(2):293-311 PMID: 11396483
  15. FHIT as tumor suppressor: mechanisms and therapeutic opportunities.
    Cancer Biol Ther. 2002 May-Jun;1(3):232-6 PMID: 12432269
  16. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
    Biochem J. 2000 Dec 1;352 Pt 2:443-8 PMID: 11085938
  17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Cancer Res. 1999 Jul 15;59(14):3333-9 PMID: 10416589
  18. Induction of apoptosis in cells by cadmium: quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate.
    Toxicol Sci. 2001 Dec;64(2):208-15 PMID: 11719703
  19. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
    Oncology. 2001;61(3):205-11 PMID: 11574776
  20. The role of the FHIT/FRA3B locus in cancer.
    Annu Rev Genet. 1998;32:7-31 PMID: 9928473
  21. Metallothioneins: new functional and structural insights.
    Curr Opin Chem Biol. 2000 Apr;4(2):177-83 PMID: 10742189
  22. Enhancement of hydroxylation and deglycosylation of 2'-deoxyguanosine by carcinogenic nickel compounds.
    Cancer Res. 1989 Nov 1;49(21):5964-8 PMID: 2790811
  23. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
    Proc Natl Acad Sci U S A. 1998 May 12;95(10):5484-9 PMID: 9576908
  24. Effects of cadmium and zinc on solar-simulated light-irradiated cells: potential role of zinc-metallothionein in zinc-induced genoprotection.
    Arch Biochem Biophys. 2002 Sep 15;405(2):170-7 PMID: 12220529
  25. Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity.
    J Toxicol Sci. 1998 Jul;23 Suppl 2:97-102 PMID: 9760441
  26. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8489-92 PMID: 10411902
  27. The histidine triad superfamily of nucleotide-binding proteins.
    J Cell Physiol. 1999 Nov;181(2):179-87 PMID: 10497298
  28. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Cancer Res. 2002 Jun 15;62(12):3477-84 PMID: 12067991
  29. MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.
    Structure. 1997 Jun 15;5(6):763-74 PMID: 9261067
  30. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis.
    Free Radic Biol Med. 2002 May 15;32(10):958-67 PMID: 12008111
  31. Carcinogenicity of nickel compounds in animals.
    IARC Sci Publ. 1984;(53):127-42 PMID: 6532978
  32. Replacement of Fhit in cancer cells suppresses tumorigenicity.
    Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13771-6 PMID: 9391102
  33. Frequent altered expression of fragile histidine triad protein in human colorectal adenomas.
    Biochem Biophys Res Commun. 2000 Nov 11;278(1):205-10 PMID: 11071873
  34. The tumor suppressor protein Fhit. A novel interaction with tubulin.
    J Biol Chem. 1999 Aug 20;274(34):24378-82 PMID: 10446217
  35. Zinc resistance impairs sensitivity to oxidative stress in HeLa cells: protection through metallothioneins expression.
    Free Radic Biol Med. 2001 Nov 15;31(10):1179-90 PMID: 11705696
  36. FHIT gene therapy prevents tumor development in Fhit-deficient mice.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3346-51 PMID: 11248081
  37. Production of metallothionein and heat-shock proteins in response to metals.
    Fundam Appl Toxicol. 1993 Jul;21(1):15-22 PMID: 8365580
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
Published
2004-01-00
Pages
195-202
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
Grants
NCI NIH HHS · N01-CO-12400 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com